Age of initiation of gender-affirming hormone therapy and mental health outcomes among transgender women, transfeminine, and non-binary adults living in the U.S.
Abstract
Background Gender-affirming hormone therapy (GAHT) is associated with improved psychosocial well-being among transgender and gender diverse (TGD) individuals, but little is known about how the timing of initiation influences adult mental health.Aims To examine associations of GAHT initiation (age and desire) with depression and gender congruence indicators among transgender women and/or transfeminine adults in the United States.Methods We conducted a secondary analysis of the 2022–2024 Transgender Women’s Internet Survey and Testing study. Participants ≥18 years were grouped by GAHT status: (1) initiated
Fields of Study & Subjects
LGBTQ Health
Identity
and Policy
Sex and Gender in Healthcare
Sexuality
Behavior
and Technology
Publication details
- Journal / source
- International Journal of Transgender Health
- Publisher
- Informa UK Limited
- Pages
- 1–13
- Publication date
- 28 February 2026
- Language
- EN